Introduction:Basic information about N-(5-CHLORO-3-PYRAZINE)-4-AMINOBENZENESULFONAININO CAS 102-65-8, including its chemical name, molecular formula, synonyms, physicochemical properties, and safety information, etc.
N-(5-CHLORO-3-PYRAZINE)-4-AMINOBENZENESULFONAININO Basic information
| Product Name: | N-(5-CHLORO-3-PYRAZINE)-4-AMINOBENZENESULFONAININO |
| Synonyms: | N-(5-CHLORO-3-PYRAZINE)-4-AMINOBENZENESULFONAININO SODIUM MONOHYDRATE;SULFACHLOROPYRAZINE SODIUM;SULFACHLOROPYRAZINE SODIUM H2O;SULFACHLORPYRAZINE SODIUM;sulfaclozine;SULFACLOZINE SODIUM;SPZ;SULFACHLOROPYRAZINE SODIUM(SPZ):N-(5-CHLORO-3-PYRAZINE)-4-AMINOBENZENESULFONAININO SODIUM MONOHYDRATE |
| CAS: | 102-65-8 |
| MF: | C10H9ClN4O2S |
| MW: | 284.72 |
| EINECS: | 203-044-0 |
| Product Categories: | pharmaceutical;Pharmaceutical intermediate;1;102-65-8 |
| Mol File: | 102-65-8.mol |
|
N-(5-CHLORO-3-PYRAZINE)-4-AMINOBENZENESULFONAININO Chemical Properties
| Melting point | 234.8-235.4 °C |
| Boiling point | 495.7±55.0 °C(Predicted) |
| density | 1.588±0.06 g/cm3(Predicted) |
| storage temp. | 2-8°C(protect from light) |
| solubility | DMSO (Slightly), Methanol (Slightly, Heated, Sonicated) |
| pka | 4.83±0.10(Predicted) |
| form | Solid |
| color | White to Off-White |
Safety Information
N-(5-CHLORO-3-PYRAZINE)-4-AMINOBENZENESULFONAININO Usage And Synthesis
| Uses | Sulfachloropyrazine sodium monohydrate is an antiprotozoal useful in coccidiosis research. |
| in vivo | Sulfaclozine (60 mg/kg; intravenous injection or oral administration; male broiler chickens) can be used primarily for the treatment of parasitic and microbial infections of the digestive tract rather than for the treatment of systemic infections[1]. | Animal Model: | 14 male broiler chickens (30-day-old)[1] | | Dosage: | 60 mg/kg | | Administration: | Intravenous injection or oral administration (Pharmacokinetic Analysis) | | Result: | Serum drug concentrations at 0.083, 0.50, 2, 6, 24 and 72h were determined to be 99.62, 83.50, 72.68, 58.43, 38.66 and 13.14 μg/mL, respectively, by intravenous injection. By oral administration were determined as 4.33, 7.95, 16.46, 22.88, 16.03 and 5.74 μg/mL, respectively. |
|
| IC 50 | Coccidia |
N-(5-CHLORO-3-PYRAZINE)-4-AMINOBENZENESULFONAININO Preparation Products And Raw materials